IBDEI1WW ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30525,0)
;;=F15.21^^120^1556^34
;;^UTILITY(U,$J,358.3,30525,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30525,1,3,0)
;;=3^Oth Stimulant Dependence,Mod/Sev,In Remission
;;^UTILITY(U,$J,358.3,30525,1,4,0)
;;=4^F15.21
;;^UTILITY(U,$J,358.3,30525,2)
;;=^5003296
;;^UTILITY(U,$J,358.3,30526,0)
;;=Z91.120^^120^1557^1
;;^UTILITY(U,$J,358.3,30526,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30526,1,3,0)
;;=3^Intentional Underdosing d/t Financial Hardship
;;^UTILITY(U,$J,358.3,30526,1,4,0)
;;=4^Z91.120
;;^UTILITY(U,$J,358.3,30526,2)
;;=^5063612
;;^UTILITY(U,$J,358.3,30527,0)
;;=Z91.128^^120^1557^2
;;^UTILITY(U,$J,358.3,30527,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30527,1,3,0)
;;=3^Intentional Underdosing,Other Reasons
;;^UTILITY(U,$J,358.3,30527,1,4,0)
;;=4^Z91.128
;;^UTILITY(U,$J,358.3,30527,2)
;;=^5063613
;;^UTILITY(U,$J,358.3,30528,0)
;;=Z91.130^^120^1557^15
;;^UTILITY(U,$J,358.3,30528,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30528,1,3,0)
;;=3^Unintented Underdosing d/t Age-Related Disability
;;^UTILITY(U,$J,358.3,30528,1,4,0)
;;=4^Z91.130
;;^UTILITY(U,$J,358.3,30528,2)
;;=^5063614
;;^UTILITY(U,$J,358.3,30529,0)
;;=Z91.138^^120^1557^16
;;^UTILITY(U,$J,358.3,30529,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30529,1,3,0)
;;=3^Unintented Underdosing,Other Reasons
;;^UTILITY(U,$J,358.3,30529,1,4,0)
;;=4^Z91.138
;;^UTILITY(U,$J,358.3,30529,2)
;;=^5063615
;;^UTILITY(U,$J,358.3,30530,0)
;;=T38.3X6A^^120^1557^3
;;^UTILITY(U,$J,358.3,30530,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30530,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,30530,1,4,0)
;;=4^T38.3X6A
;;^UTILITY(U,$J,358.3,30530,2)
;;=^5049649
;;^UTILITY(U,$J,358.3,30531,0)
;;=T38.3X6S^^120^1557^4
;;^UTILITY(U,$J,358.3,30531,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30531,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
;;^UTILITY(U,$J,358.3,30531,1,4,0)
;;=4^T38.3X6S
;;^UTILITY(U,$J,358.3,30531,2)
;;=^5049651
;;^UTILITY(U,$J,358.3,30532,0)
;;=T38.3X6D^^120^1557^5
;;^UTILITY(U,$J,358.3,30532,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30532,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
;;^UTILITY(U,$J,358.3,30532,1,4,0)
;;=4^T38.3X6D
;;^UTILITY(U,$J,358.3,30532,2)
;;=^5049650
;;^UTILITY(U,$J,358.3,30533,0)
;;=T46.5X6A^^120^1557^9
;;^UTILITY(U,$J,358.3,30533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30533,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,30533,1,4,0)
;;=4^T46.5X6A
;;^UTILITY(U,$J,358.3,30533,2)
;;=^5051353
;;^UTILITY(U,$J,358.3,30534,0)
;;=T46.5X6D^^120^1557^10
;;^UTILITY(U,$J,358.3,30534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30534,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
;;^UTILITY(U,$J,358.3,30534,1,4,0)
;;=4^T46.5X6D
;;^UTILITY(U,$J,358.3,30534,2)
;;=^5051354
;;^UTILITY(U,$J,358.3,30535,0)
;;=T46.5X6S^^120^1557^11
;;^UTILITY(U,$J,358.3,30535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30535,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Sequela
;;^UTILITY(U,$J,358.3,30535,1,4,0)
;;=4^T46.5X6S
;;^UTILITY(U,$J,358.3,30535,2)
;;=^5051355
;;^UTILITY(U,$J,358.3,30536,0)
;;=T43.206A^^120^1557^6
;;^UTILITY(U,$J,358.3,30536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30536,1,3,0)
;;=3^Underdosing of Antidepressants,Init Encntr
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1WW 3803 printed Apr 09, 2024@21:10:06 Page 2
IBDEI1WW ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30525,0)
+2 ;;=F15.21^^120^1556^34
+3 ;;^UTILITY(U,$J,358.3,30525,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,30525,1,3,0)
+6 ;;=3^Oth Stimulant Dependence,Mod/Sev,In Remission
+7 ;;^UTILITY(U,$J,358.3,30525,1,4,0)
+8 ;;=4^F15.21
+9 ;;^UTILITY(U,$J,358.3,30525,2)
+10 ;;=^5003296
+11 ;;^UTILITY(U,$J,358.3,30526,0)
+12 ;;=Z91.120^^120^1557^1
+13 ;;^UTILITY(U,$J,358.3,30526,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,30526,1,3,0)
+16 ;;=3^Intentional Underdosing d/t Financial Hardship
+17 ;;^UTILITY(U,$J,358.3,30526,1,4,0)
+18 ;;=4^Z91.120
+19 ;;^UTILITY(U,$J,358.3,30526,2)
+20 ;;=^5063612
+21 ;;^UTILITY(U,$J,358.3,30527,0)
+22 ;;=Z91.128^^120^1557^2
+23 ;;^UTILITY(U,$J,358.3,30527,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,30527,1,3,0)
+26 ;;=3^Intentional Underdosing,Other Reasons
+27 ;;^UTILITY(U,$J,358.3,30527,1,4,0)
+28 ;;=4^Z91.128
+29 ;;^UTILITY(U,$J,358.3,30527,2)
+30 ;;=^5063613
+31 ;;^UTILITY(U,$J,358.3,30528,0)
+32 ;;=Z91.130^^120^1557^15
+33 ;;^UTILITY(U,$J,358.3,30528,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,30528,1,3,0)
+36 ;;=3^Unintented Underdosing d/t Age-Related Disability
+37 ;;^UTILITY(U,$J,358.3,30528,1,4,0)
+38 ;;=4^Z91.130
+39 ;;^UTILITY(U,$J,358.3,30528,2)
+40 ;;=^5063614
+41 ;;^UTILITY(U,$J,358.3,30529,0)
+42 ;;=Z91.138^^120^1557^16
+43 ;;^UTILITY(U,$J,358.3,30529,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,30529,1,3,0)
+46 ;;=3^Unintented Underdosing,Other Reasons
+47 ;;^UTILITY(U,$J,358.3,30529,1,4,0)
+48 ;;=4^Z91.138
+49 ;;^UTILITY(U,$J,358.3,30529,2)
+50 ;;=^5063615
+51 ;;^UTILITY(U,$J,358.3,30530,0)
+52 ;;=T38.3X6A^^120^1557^3
+53 ;;^UTILITY(U,$J,358.3,30530,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,30530,1,3,0)
+56 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
+57 ;;^UTILITY(U,$J,358.3,30530,1,4,0)
+58 ;;=4^T38.3X6A
+59 ;;^UTILITY(U,$J,358.3,30530,2)
+60 ;;=^5049649
+61 ;;^UTILITY(U,$J,358.3,30531,0)
+62 ;;=T38.3X6S^^120^1557^4
+63 ;;^UTILITY(U,$J,358.3,30531,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,30531,1,3,0)
+66 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
+67 ;;^UTILITY(U,$J,358.3,30531,1,4,0)
+68 ;;=4^T38.3X6S
+69 ;;^UTILITY(U,$J,358.3,30531,2)
+70 ;;=^5049651
+71 ;;^UTILITY(U,$J,358.3,30532,0)
+72 ;;=T38.3X6D^^120^1557^5
+73 ;;^UTILITY(U,$J,358.3,30532,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,30532,1,3,0)
+76 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
+77 ;;^UTILITY(U,$J,358.3,30532,1,4,0)
+78 ;;=4^T38.3X6D
+79 ;;^UTILITY(U,$J,358.3,30532,2)
+80 ;;=^5049650
+81 ;;^UTILITY(U,$J,358.3,30533,0)
+82 ;;=T46.5X6A^^120^1557^9
+83 ;;^UTILITY(U,$J,358.3,30533,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,30533,1,3,0)
+86 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
+87 ;;^UTILITY(U,$J,358.3,30533,1,4,0)
+88 ;;=4^T46.5X6A
+89 ;;^UTILITY(U,$J,358.3,30533,2)
+90 ;;=^5051353
+91 ;;^UTILITY(U,$J,358.3,30534,0)
+92 ;;=T46.5X6D^^120^1557^10
+93 ;;^UTILITY(U,$J,358.3,30534,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,30534,1,3,0)
+96 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
+97 ;;^UTILITY(U,$J,358.3,30534,1,4,0)
+98 ;;=4^T46.5X6D
+99 ;;^UTILITY(U,$J,358.3,30534,2)
+100 ;;=^5051354
+101 ;;^UTILITY(U,$J,358.3,30535,0)
+102 ;;=T46.5X6S^^120^1557^11
+103 ;;^UTILITY(U,$J,358.3,30535,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,30535,1,3,0)
+106 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
+107 ;;^UTILITY(U,$J,358.3,30535,1,4,0)
+108 ;;=4^T46.5X6S
+109 ;;^UTILITY(U,$J,358.3,30535,2)
+110 ;;=^5051355
+111 ;;^UTILITY(U,$J,358.3,30536,0)
+112 ;;=T43.206A^^120^1557^6
+113 ;;^UTILITY(U,$J,358.3,30536,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,30536,1,3,0)
+116 ;;=3^Underdosing of Antidepressants,Init Encntr
